Shenzhen Burui Biotechnology Co.
Latest round
- Series A
Last raised
- Feb 2022
Total raised
- Undisclosed
Investors
- 2
About Shenzhen Burui Biotechnology Co.
, Ltd operates as a screening and diagnosis solutions provider, focusing on breath detection and disease biomarker research. The company's CEO and founder, Mr. Alan Wang, who is responsible for directing all aspects of company strategy, planning, and operations. He had served as the vice president of 12 SIGMA Technologies, and the director of the surgical product department of Olympus China. The company has cooperated with many hospitals in medical research projects related to several serious diseases such as tuberculosis, lung cancer, and esophageal cancer. In January 2022, its Hunan production base has passed the GMP certification. In December 2019, its experimental product SCENT-I began testing samples for tuberculosis, lung cancer and esophageal cancer in collaboration with hospitals. The company's product is composed of the hardware part of human exhaled breath detection mass spectrometer and the software part of artificial intelligence technology. It is a precise detection and analysis platform for the volatile organic compounds (VOCs) in human exhaled breath. The Scents A-3 is a single photon ionization-time of flight mass spectrometry (SPI-TOFMS), which can be used for online and real-time monitoring of VOCs at pptv level. It contains features such as low detection limit, high sensitivity, and controllable fragmentation.
Who invested in Shenzhen Burui Biotechnology Co.
2 investors across 1 round
See all investors in Shenzhen Burui Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 18, 2022
Amount
Undisclosed
Investors
Questions about Shenzhen Burui Biotechnology Co.
Who invested in Shenzhen Burui Biotechnology Co.?
Shenzhen Burui Biotechnology Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shenzhen Burui Biotechnology Co. raised?
Shenzhen Burui Biotechnology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Shenzhen Burui Biotechnology Co. last raise money?
Shenzhen Burui Biotechnology Co.'s most recent round on record is a Series A, in Feb 2022.
What does Shenzhen Burui Biotechnology Co. do?
, Ltd operates as a screening and diagnosis solutions provider, focusing on breath detection and disease biomarker research.
Where is Shenzhen Burui Biotechnology Co. headquartered?
Shenzhen Burui Biotechnology Co. is headquartered in Shenzhen, China.
Which VCs invest in companies like Shenzhen Burui Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Shenzhen Burui Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Shenzhen Burui Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.